Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07388615
PHASE2
The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children
Sponsor: Al-Azhar University
View on ClinicalTrials.gov
Summary
This study aims to: 1. To evaluate the effectiveness of Immulant ® addition to standard treatment in reducing clinical symptoms of Cryptosporidiosis in immunocompromised children. 2. To measure the changes in parasite count in stool samples after treatment with Immulant ®. 3. To assess the safety and tolerability of Immulant ® in children participating in the study.
Key Details
Gender
All
Age Range
5 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-01-18
Completion Date
2026-08
Last Updated
2026-02-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
Echinacea Extract
Immulant ® (an extract derived from Echinacea purpurea plant)
Locations (1)
National Nutritional Institute
Cairo, Egypt